Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Int J Health Econ Manag. 2020 Apr 30;20(3):299–317. doi: 10.1007/s10754-020-09282-2

Figure II: Adjusted use of Dronedarone by provider characteristics, 2009–2013.

Figure II:

Figure II:

Notes: Estimates represent fitted values from multivariate regression models that adjust for patient race/ethnicity, SES, rurality, age, sex, and Charlson comorbidity index, and for provider age, sex, and specialty. The vertical lines indicate when the de-adoption evidence was introduced (November 2011).